Series A · Data & Analytics · Barcelona, Spain · Founded 2018 · 100–130 employees
Seqera develops data orchestration and workflow software for life sciences, built around the open-source Nextflow platform that is used by over 100,000 scientists globally. The company raised €22 million in Series A funding in October 2022, following strong growth with 400% year-over-year revenue increase and tripling of employees. Their technology was pivotal in COVID-19 variant detection and is used by leading pharmaceutical companies including AstraZeneca and Janssen Pharmaceuticals. Seqera is transforming how researchers process complex genomic data in multi-cloud environments, making it a key enabler for breakthroughs in drug discovery and precision medicine.